Wednesday, March 18, 2026
Time:
12:30 PM Eastern / 11:30 AM Central / 10:30 AM Mountain / 9:30 AM Pacific
This webinar will provide essential legal insights into peptide and GLP-1 compounding by 503A pharmacies and 503B outsourcing facilities. The presentation will address FDA and State Board of Pharmacy enforcement trends, how to respond to regulatory actions, consequences resulting from the end of the GLP-1 shortage, and the evolving role of telemedicine.
We will also discuss private litigation undertaken by Novo Nordisk and Eli Lilly. Attendees will receive up-to-date, actionable information to help pharmacists and pharmacy technicians remain compliant in this rapidly evolving regulatory environment.
Pricing:
Member: $40
Non-Member: $50
Special pricing available for Pharmacy Technicians and Student Pharmacists
